Glaxo Claims OTC Switch Dominance With An Eye Toward Xenical In 2006
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline believes an OTC switch of the prescription weight-loss drug Xenical (orlistat) could have the same success as its nonprescription nicotine replacement therapy offerings